FDA's New Rules for Lab Developed Tests (LDTs) Explained | Experts Share What Labs Need to Know

Описание к видео FDA's New Rules for Lab Developed Tests (LDTs) Explained | Experts Share What Labs Need to Know

In our first episode of the NQ8 Podcast, we’re thrilled to host Dr. Tiffany Bratton, NQ8’s Chief Medical Officer and diagnostics expert. Dr. Bratton dives into the FDA’s new rules reclassifying Laboratory Developed Tests (LDTs) as In Vitro Diagnostics (IVDs) under FDA Rule 809. Discover what these changes mean for your lab, the challenges of transitioning, and the steps labs need to take to stay compliant in 2025 and beyond.

If you’re a lab director, regulatory manager, or diagnostics innovator, this episode will guide you through what it takes to align with FDA’s stringent new requirements and prepare for the future of lab testing.

👉 Subscribe and Watch now to get your lab #FDAReady!

Комментарии

Информация по комментариям в разработке